Free Newsletter
Urology trial goes e-PRO
A large--but unnamed--drugmaker conducting a Phase II trial for a urology treatment will use electronic diaries to collect patient-reported outcome data. The 750-subject trial spans 22 countries on three continents and requires use of 34 languages, according to an announcement.
The sponsor selected the etrials eDiary 5.0 platform from Merge Healthcare. The manufacturer's eDiary Inventory Module, for tracking the shipping and supply of study data-capture devices, will also be used.
The eDiary 5.0 software, based on the Windows Mobile operating system, runs a ruggedized handheld device, the manufacturer says. Patients enter outcomes data using the device and then upload the data to a centralized electronic repository, where it is accessible to trial managers in real time.
- here's the announcement
Related Article:
Medidata plans Mass. blitz
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities


SHARE
WITH: